FIG. 05 / TYME TECHNOLOGIES

From unknown to listed.

Brand awareness from zero, plus the IR materials that carried Tyme through their NASDAQ transition. Documented the opening bell.

Client: Tyme Technologies
Sector: Oncology
Category: Biotech
Status: NASDAQ: TYME

FIG. 05.A / Image to be supplied

FIG. 05.A / Tyme Technologies brand application. Photography in production.

The Brief

Tyme Technologies is an oncology-focused biotech. When they engaged us, they were a private company with limited brand presence and an upcoming public transition.

They needed to establish a brand strategy and online presence sophisticated enough to support investor and clinician engagement, then navigate the IR/IPO website transition.

The Argument

We built a brand strategy that read as the public company they were about to become, not the private startup they technically still were on the day of the kickoff.

Social media became the bridge: investor and clinician engagement compounded ahead of the listing, so the listing day was a milestone in a momentum, not a starting line.

The Work

Brand strategy, website, social media, abstract posters, investor presentation, and tradeshow display.

IR/IPO website transition coordinated with the NASDAQ uplisting. The corporate brand survived the regulatory transition with the same voice it had as a private company.

From unknown biotech to Instagram leader, then to NASDAQ.

325 / Tyme case file

FIG. 05.B / NASDAQ transitions completed

01tx

A successful NASDAQ uplisting from a starting position of negligible brand presence. The IR materials carried the work, but the brand made the materials credible.

325 / Tyme / NASDAQ uplisting

Capabilities applied